Skip to content
OpenCapital
Get started

Pacific Biosciences of California PACB Q3 2025 earnings

Reported November 5, 2025 · After market close

Revenue$38.4MMiss by $6.2M
EPS-$0.12Beat by $0.04
Revenue estimate$44.6M
EPS estimate-$0.16

Next report

Aug 3, 2026 (In 5 days)
Revenue estimate$42.9M
EPS estimate-$0.13

Financials

Q3 2025

Income statement

See full
Revenue$38.4M-3.8%
Gross profit$15.9M+58.9%
Operating income-$38.9M+39.3%
Net income-$38.0M+37.4%
EPS (diluted)-$0.13+40.9%

Balance sheet

See full
Cash & equivalents$58.3M-27.3%
Total debt$54.9M+98.9%
Total equity$36.1M-92.0%
Total assets$803.2M-44.6%

Cash flow

See full
Operating cash flow-$18.7M+58.9%
CapEx-—
Free cash flow-$18.6M+58.3%

Valuation & ratios

Valuation

as of 09/30/25
See full
Market cap$384.47M-17.0%
Enterprise value$381.1M-7.2%
P/S2.5×-0.2×

Profitability

See full
Gross margin25.4%+4.2pp
Operating margin-430.6%+2,013pp
Net margin-327.3%+255pp
FCF margin-81.7%-23.7pp

Returns & leverage

See full
Return on equity-206.9%-380pp
Debt / equity1.5×+1.5×
Current ratio6.2×-3.5×

Segments

By product

See full
Consumable revenue$21.3M+15.0%
Instrument revenue$11.3M-32.6%
Service And Other$5.8M+25.1%
Service and other revenue$5.8M+25.1%

By geography

See full
Americas$18.1M-10.0%
Europe, Middle East and Africa$10.8M+17.9%
Asia-Pacific$9.6M-10.7%

By segment

See full
Reportable Segment$38.4M-3.8%

Versus estimates

Revenue

Q1 2026$37.2MMiss by $2.8MQ4 2025$44.6MBeat by $1.6M
Q3 2025$38.4MMiss by $6.2M
Q2 2025$39.8MMiss by $181.9KQ1 2025$37.2MBeat by $253.0KQ4 2024$39.2MMiss by $1.5M

Diluted EPS

Q1 2026-$0.12Beat by $0.05Q4 2025-$0.12Beat by $0.07
Q3 2025-$0.12Beat by $0.04
Q2 2025-$0.13Beat by $0.05Q1 2025-$0.15Beat by $0.04Q4 2024-$0.20In line

Ask the moment Pacific Biosciences of California reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

When did Pacific Biosciences of California report Q3 2025 earnings?
Pacific Biosciences of California (PACB) reported Q3 2025 earnings on November 5, 2025 after market close.
What were Pacific Biosciences of California's Q3 2025 revenue and EPS?
Pacific Biosciences of California reported revenue of $38.4M and eps of $-0.12 for Q3 2025.
Did Pacific Biosciences of California beat estimates in Q3 2025?
Revenue missed the consensus estimate of $44.6M by $6.2M. EPS beat the consensus estimate of $-0.16 by $0.04.
How did Pacific Biosciences of California's Q3 2025 results compare year-over-year?
Compared to the same quarter a year prior, revenue declined 3.8% from $40.0M a year earlier and eps grew 45.5% from $-0.22.
Where can I find Pacific Biosciences of California's Q3 2025 SEC filings?
You can read the 8-K earnings release (0001299130-25-000165) and the 10-Q periodic report (0001299130-25-000168) directly on SEC EDGAR. The filing index links above go to sec.gov.